Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions
Adam P Ostendorf,1 Yu-Tze Ng2 1Department of Pediatrics, Neurology Section, Nationwide Children’s Hospital, The Ohio State University, Columbus, OH, 2Department of Pediatrics, Baylor College of Medicine, The Children’s Hospital of San Antonio, San Antonio, TX, USA Abstract: Len...
Guardado en:
Autores principales: | Ostendorf AP, Ng YT |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/602d57df195d46dc9b7dc3c75d0b12ec |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Truncating mutation in TANC2 in a Chinese boy associated with Lennox-Gastaut syndrome: a case report
por: Yang Tian, et al.
Publicado: (2021) -
Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review
por: Balagura G, et al.
Publicado: (2020) -
Case Report: Lennox–Gastaut Epileptic Encephalopathy Responsive to Cannabidiol Treatment Associated With a Novel de novo Mosaic SHANK1 Variant
por: Justyna Paprocka, et al.
Publicado: (2021) -
Rufinamide in patients with Lennox-Gastaut syndrome
por: Clark PO, et al.
Publicado: (2016) -
Atlas epilepsy care in the world.
Publicado: (2005)